Literature DB >> 35831487

Autoimmune obsessive-compulsive disorder with novel anti-CNS autoantibodies in cerebrospinal fluid.

Miriam A Schiele1, Ludger Tebartz van Elst1, Dominique Endres2, Benjamin Pankratz1, Tilman Robinson3, Karoline Pitsch1, Theresa Göbel1, Kimon Runge1, Andrea Schlump1, Kathrin Nickel1, Marco Reisert4,5, Horst Urbach6, Ulrich Voderholzer1,7,8, Nils Venhoff9, Katharina Domschke1,10, Harald Prüss11,12.   

Abstract

Entities:  

Year:  2022        PMID: 35831487     DOI: 10.1038/s41380-022-01688-3

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   13.437


× No keyword cloud information.
  7 in total

1.  Integration of quanta in cerebellar granule cells during sensory processing.

Authors:  Paul Chadderton; Troy W Margrie; Michael Häusser
Journal:  Nature       Date:  2004-04-22       Impact factor: 49.962

Review 2.  Glutamate abnormalities in obsessive compulsive disorder: neurobiology, pathophysiology, and treatment.

Authors:  Christopher Pittenger; Michael H Bloch; Kyle Williams
Journal:  Pharmacol Ther       Date:  2011-09-22       Impact factor: 12.310

Review 3.  Anti-rods/rings autoantibody and IMPDH filaments: an update after fifteen years of discovery.

Authors:  S John Calise; Edward K L Chan
Journal:  Autoimmun Rev       Date:  2020-08-15       Impact factor: 9.754

4.  Glucose-regulated protein 78 autoantibody associates with blood-brain barrier disruption in neuromyelitis optica.

Authors:  Fumitaka Shimizu; Kristin L Schaller; Gregory P Owens; Anne C Cotleur; Debra Kellner; Yukio Takeshita; Birgit Obermeier; Thomas J Kryzer; Yasuteru Sano; Takashi Kanda; Vanda A Lennon; Richard M Ransohoff; Jeffrey L Bennett
Journal:  Sci Transl Med       Date:  2017-07-05       Impact factor: 17.956

Review 5.  Autoantibodies in neurological disease.

Authors:  Harald Prüss
Journal:  Nat Rev Immunol       Date:  2021-05-11       Impact factor: 53.106

Review 6.  Immunological causes of obsessive-compulsive disorder: is it time for the concept of an "autoimmune OCD" subtype?

Authors:  Katharina Domschke; Ludger Tebartz van Elst; Miriam A Schiele; Dominique Endres; Thomas A Pollak; Karl Bechter; Dominik Denzel; Karoline Pitsch; Kathrin Nickel; Kimon Runge; Benjamin Pankratz; David Klatzmann; Ryad Tamouza; Luc Mallet; Marion Leboyer; Harald Prüss; Ulrich Voderholzer; Janet L Cunningham
Journal:  Transl Psychiatry       Date:  2022-01-10       Impact factor: 6.222

7.  A Therapeutic Non-self-reactive SARS-CoV-2 Antibody Protects from Lung Pathology in a COVID-19 Hamster Model.

Authors:  Jakob Kreye; S Momsen Reincke; Hans-Christian Kornau; Elisa Sánchez-Sendin; Victor Max Corman; Hejun Liu; Meng Yuan; Nicholas C Wu; Xueyong Zhu; Chang-Chun D Lee; Jakob Trimpert; Markus Höltje; Kristina Dietert; Laura Stöffler; Niels von Wardenburg; Scott van Hoof; Marie A Homeyer; Julius Hoffmann; Azza Abdelgawad; Achim D Gruber; Luca D Bertzbach; Daria Vladimirova; Lucie Y Li; Paula Charlotte Barthel; Karl Skriner; Andreas C Hocke; Stefan Hippenstiel; Martin Witzenrath; Norbert Suttorp; Florian Kurth; Christiana Franke; Matthias Endres; Dietmar Schmitz; Lara Maria Jeworowski; Anja Richter; Marie Luisa Schmidt; Tatjana Schwarz; Marcel Alexander Müller; Christian Drosten; Daniel Wendisch; Leif E Sander; Nikolaus Osterrieder; Ian A Wilson; Harald Prüss
Journal:  Cell       Date:  2020-09-23       Impact factor: 41.582

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.